Oocyte cryopreservation in a transgender man on long-term testosterone therapy: a case report

[1]  I. Yaish,et al.  Ovarian stimulation outcomes among transgender men compared with fertile cisgender women , 2020, Journal of Assisted Reproduction and Genetics.

[2]  Y. Greenman,et al.  Fertility preservation rates among transgender women compared with transgender men receiving comprehensive fertility counselling. , 2020, Reproductive biomedicine online.

[3]  E. Ginsburg,et al.  Fertility Preservation for Adolescent Transgender Male Patients: A Case Series. , 2020, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[4]  Clare Bartholomaeus,et al.  Transgender and non-binary Australians’ experiences with healthcare professionals in relation to fertility preservation , 2020, Culture, health & sexuality.

[5]  D. Sakkas,et al.  Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine. , 2019, Fertility and sterility.

[6]  M. Palmert,et al.  Perspectives on fertility preservation and parenthood among transgender youth and their parents , 2019, Archives of Disease in Childhood.

[7]  M. Menke,et al.  Oocyte Cryopreservation in a Transgender Male Adolescent. , 2019, The New England journal of medicine.

[8]  G. Quinn,et al.  Health care provider perceptions of fertility preservation barriers and challenges with transgender patients and families: qualitative responses to an international survey , 2019, Journal of Assisted Reproduction and Genetics.

[9]  Clare Bartholomaeus,et al.  Fertility preservation decision making amongst Australian transgender and non-binary adults , 2018, Reproductive Health.

[10]  M. Moravek,et al.  Oocyte cryopreservation among transmasculine youth: a case series , 2018, Journal of assisted reproduction and genetics.

[11]  M. Murad,et al.  ENDOCRINE TREATMENT OF GENDER-DYSPHORIC/GENDER-INCONGRUENT PERSONS: AN ENDOCRINE SOCIETY CLINICAL PRACTICE GUIDELINE. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[12]  P. Cohen-Kettenis,et al.  Endocrine Treatment of Gender‐Dysphoric/Gender‐Incongruent Persons: An Endocrine Society* Clinical Practice Guideline , 2017, The Journal of clinical endocrinology and metabolism.

[13]  D. Keefe,et al.  Pregnancy Outcomes After Fertility Preservation in Transgender Men. , 2017, Obstetrics and gynecology.

[14]  K. Braeckmans,et al.  Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment. , 2017, Reproductive biomedicine online.

[15]  K. Mitu.  Transgender Reproductive Choice and Fertility Preservation. , 2016, AMA journal of ethics.

[16]  A. Decherney,et al.  Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response. , 2016, Fertility and sterility.

[17]  P. De Sutter,et al.  Fertility options in transgender people , 2016, International review of psychiatry.

[18]  B. Kreukels,et al.  Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy. , 2015, Fertility and sterility.

[19]  Access to fertility services by transgender persons: an Ethics Committee opinion. , 2015, Fertility and sterility.

[20]  B. Tarlatzis,et al.  ESHRE Task Force on Ethics and Law 23: medically assisted reproduction in singles, lesbian and gay couples, and transsexual people†. , 2014, Human reproduction.

[21]  G. Pennings,et al.  Reproductive wish in transsexual men. , 2012, Human reproduction.

[22]  L. Gooren,et al.  Ovarian morphology in long‐term androgen‐treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? , 1991, Histopathology.